Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency on immunoglobulin G (IgG) and then be restabilized on IgG before being randomized to placebo or one of two doses of subcutaneous immunoglobul...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Peripher Nerv Syst
Päätekijät: Lewis, Richard A., Cornblath, David R., Hartung, Hans‐Peter, Sobue, Gens, Lawo, John‐Philip, Mielke, Orell, Durn, Billie L., Bril, Vera, Merkies, Ingemar S. J., Bassett, Paul, Cleasby, Alexa, van Schaik, Ivo N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wiley Periodicals, Inc. 2020
Aiheet:
Research Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497019/
https://ncbi.nlm.nih.gov/pubmed/32627277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12402
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia